Company profile
Sinorda Biomedicine company profile
Sinorda Biomedicine develops medicine and the industrialization of tumor immunotherapy. Their disease treatment program includes anti-tumor sentinel lymph node t-cell therapy, oncolytic virus therapy, tumor-infiltrating t-cell therapy, natural killer cell therapy, dendritic cell therapy, killer t-cell therapy, and tumor immune index monitoring. They also provide immune cell isolation and cryopreservation, accurate genetic testing, and immune function test.
Business identity
- Website
- http://www.sinorda.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2014-01-01, Year
Headquarters
- Headquarters
- Haocun, Fujian, China
- Postal code
- 550000
- Country code
- CN
- Continent
- Asia